Randomized phase II trial of fulvestrant alone or in combination with bortezomib in hormone receptor-positive metastatic breast cancer resistant to aromatase inhibitors: a New York Cancer Consortium trial
一项随机II期临床试验,评估氟维司群单药或联合硼替佐米治疗对芳香化酶抑制剂耐药的激素受体阳性转移性乳腺癌的疗效:纽约癌症联盟试验
期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/npjbcancer.2016.37
Adelson, Kerin; Ramaswamy, Bhuvaneswari; Sparano, Joseph A; Christos, Paul J; Wright, John J; Raptis, George; Han, Gang; Villalona-Calero, Miguel; Ma, Cynthia X; Hershman, Dawn; Baar, Joseph; Klein, Paula; Cigler, Tessa; Budd, G Thomas; Novik, Yelena; Tan, Antoinette R; Tannenbaum, Susan; Goel, Anupama; Levine, Ellis; Shapiro, Charles L; Andreopoulou, Eleni; Naughton, Michael; Kalinsky, Kevin; Waxman, Sam; Germain, Doris